Form D · Biotechnology
CeloNova BioSciences, Inc.
Peachtree City, GA · CIK 0001510561
Offering snapshot reported Feb 15, 2011 · SEC filing
- Reported sold
- $20.8M Offering amount: $20.8M
- Investors reported
- 81 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 1, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 15, 2011 | Initial | $20,841,869 | No comparison | 81 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-155411
Source: Form D, filed Feb 15, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Grunze | Director |
| Harry R. Jacobson | Director |
| Thomas W. Lyles, Jr. | Director, Executive |
| Goetz Richter | Director |
| Dennert O. Ware | Director, Executive |
| Delores P. Williams | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
401 Westpark Court Suite 100
Peachtree City, GA, 30269
Peachtree City, GA, 30269